NOT YET RECRUITINGNA

iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer

This trial is aimed to better understand the impact of migration history on the quality of life of Black immigrant CaP survivors (both SSAI and CI). We will illuminate the full range of racial, social, environmental, behavioral, and structural factors associated with the Black immigrant experience in the US using a SDOH model.

Sponsor

M.D. Anderson Cancer Center

Enrollment

40 participants

Sites

1 locations

Start Date

January 2026

Completion

March 2026

Prostate CancerInterviews

Enrollment & Timeline

Not Yet Recruiting

Target enrollment (estimated)

Target N

participants

Sites

locations

Duration

2.2 years

total trial span

Rate

pts/month needed

Jan 2026Month 3 of 26Mar 2026

12% of trial timeline elapsed23 months to primary endpoint

At 1 sites, each site needs to enroll approximately 2.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Safety and Adverse Events (AEs)

Through study completion; an average of 1 year

Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

NOT YET RECRUITINGNA

iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer

Sponsor

M.D. Anderson Cancer Center

Enrollment

40 participants

Sites

1 locations

Start Date

January 2026

Completion

March 2026

Prostate CancerInterviews

Enrollment & Timeline

Not Yet Recruiting

Target enrollment (estimated)

Target N

participants

Sites

locations

Duration

2.2 years

total trial span

Rate

pts/month needed

Jan 2026Month 3 of 26Mar 2026

12% of trial timeline elapsed23 months to primary endpoint

At 1 sites, each site needs to enroll approximately 2.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Safety and Adverse Events (AEs)

Through study completion; an average of 1 year

Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Eligibility

Min Age

18 Years

Sex

male

Healthy Volunteers

View full criteria

Inclusion Criteria:

* be male adults (≥18 years old)
* Self-identify as CI and SSAI
* Self-identify as Black or African American
* Have been diagnosed with CaP within the last 10 years
* Have a U.S. address
* Can read and write in English

Exclusion Criteria:

• None

iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)